Michelle McMurry-Heath

Michelle McMurry-Heath (board member) discloses dealings in 2 companies, chiefly Bioventus Inc. and Revvity, Inc. We count 16 filings; the first trade dates from 16 June 2022 and the latest from 2 June 2026.

The open-market record consists of 5 sales worth €529k, with no purchase. Outside the open market, there are 4 share grants and 7 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

Most recently, on 4 June 2026, the filings show an option exercise in Bioventus Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.